Marco Costa

Name: Marco Alves da Costa
Birthplace: Viana do Castelo, Portugal at 3th December 1969
Adress: Rua Pedro Monteiro, 14-16, 3000-329 Coimbra – Portugal
Email: marcocostacard@sapo.pt
OM nº 35242 Member of Portuguese Medical Association
ESC nº 108882 Member of European Society of Cardiology
SPC nº 1533 Member of Portuguese Society of Cardiology
APIC nº 77 Member of Portuguese Association of Cardiovascular Intervention

PAST FUNCTIONS

1987-1993 School of Medicine, Universidade de Coimbra, Portugal
1994-1997 Internship in General Medicine and Internal Medicine, Hospitais da Universidade de Coimbra
1998-2002 Fellowship at Cardiology Department, Hospitais da Universidade de Coimbra
2000-2001 Member of the Council of Cardiology Portuguese Foundation
2009-2011 Secretary of the Council of Portuguese Society of Cardiology
2011-2013 Voting Member of the General Meeting Board of Portuguese Association of Cardiovascular Intervention – APIC
2011-2013 Coordinator of Interventional Cardiology Registry by National Center for Data Collection in Cardiology of Portuguese Society of Cardiology
2013-2015 General Secretary of Portuguese Association of Cardiovascular Intervention – APIC
2013-2015 Main Coordinator of National Interventional Cardiology Registry
2013 and 2014 President of Scientific Committee of Annual Meeting of APIC
2014-2016 Member of the Board of Education and Training Committee of European Association of Percutaneous Cardiovascular Interventions
2015-2017 President of General Assembly of Portuguese Association of Cardiovascular Intervention (APIC-SPC)
2015-2017 Member of Coordination Committee of National Center for Data Collection in Cardiology of Portuguese Society of Cardiology

 

 

DEGREES

Medical Degree since October 1993 by the Faculdade de Medicina de Coimbra, Portugal

Medical Specialisation in Cardiology since February 2002 (by the National Health Service and Portuguese College of Phisicians)

European Cardiologist since 2004

Subspecialisation in Interventional Cardiology since 2008

 

PRESENT FUNCTIONS

Vice-President of Portuguese Society of Cardiology for 2017-2019

Executive Director of National Center for Data Collection in Cardiology of Portuguese Society of Cardiology for 2017-2019.

Main Coordinator in Cardiovascular Interventional Unit of HG-CHUC

Member of Cardiology Department Staff of Hospital and University Center of Coimbra – General Hospital (CHUC-HG).

Main Coordinator of Fellowship in Cardiology at CHUC-HG.

Interventional Cardiologist in Hemodynamic Laboratory of HG- CHUC

Proctor in Intracardiac Echo guidance of Strutural Disease Intervention

Proctor in Strutural Disease Intervention (Patent Foramen Ovale, Atrial Septal Defects and Left Atrial appendage Closure)

Proctor in Rotational Atherectomy

Course Director of «ICE in the CathLab» (training of european cardiology fellows in intracardiac echo)

Course Director of «UNIC ComVida» (training of young portuguese interventional cardiologists in complex coronary intervention)

Member of Reviewer Council of Portuguese Journal of Cardiology (Interventional Cardiology and Structural Disease Intervention)

Member of Reviewer Council of Brazilian Archives of Cardiology (Interventional Cardiology and Structural Disease Intervention)

Reviewer of abstracts in Paris Course Revascularization (PCR) and Transcatheter Cardiovascular Therapeutics (TCT)

Regional Coordinator of Stent-for-Life (Center Region of Portugal)

Advisory Board member of Bayer, Medtronic, Abbott, Bristol Myers Squibb and Merck Sharp & Dohme, Terumo, AstraZeneca, Daiichi Sankyo, Boston.

 

PUBLICATIONS

98 publications in different fields of interest (2.814 reads, 236 citations, 33.52 RG score – higher than 92.5% of ResearchGate members, from 99.93% publications)

www.researchgate.net/profile/Marco_Costa18/reputation

 

Articles of the year 2017:

Costa M.

Radial access in cardiac catheterization: Can we do even Better?

Rev Port Cardiol.2017;36(6):415-416

Radial access in cardiac catheterization: Can we do even better?


Costa M.

Comment on “Evolucumab and Clinical Outcomes in Patients with Cardiovascular Disease”.

Rev Port Cardiol.2017;36(6):485-486

Comment on “Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease”


Costa M.

Percutaneous closure of prosthetic paravalvular leaks – should it be considered the first therapeutic option?

Rev Port Cardiol. 2017;36(7-8):495—497

Percutaneous closure of prosthetic paravalvular leaks – should it be considered the first therapeutic option?


STUDIES

Main Investigator of the following studies: EUROPA, VALUE, IMISH, ASSENT IV, SHINE, SEPIA, EXPORT, PROTECT, CLARIFY, TAO, SIGNIFY, Re-DUAL PCI, REPARA, GLOBAL SYMPLICITY REGISTRY, ENTRUST AF-PCI.

Co-investigator in several other studies

Training in Good Clinical Practice (GCP) since 2012